Conference
Assessing the long-term efficacy and safety of MV140 sublingual bacterial vaccine in the initial cohort: A 9-year study in the UK for treating recurrent urinary tract infections in men and women
Authors
Kanabar S; Foley S; Yang B
Volume
85
Pagination
pp. S1037-S1037
Publisher
ELSEVIER
Publication Date
March 1, 2024
Conference proceedings
EUROPEAN UROLOGY
ISSN
0302-2838